We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I’ve fielded has been “When will Multaq® be available?” That happened this week, and the excitement they have shared with us has been palpable.
So, on behalf of the atrial fibrillation patient community, StopAfib.org felt it was appropriate to thank and applaud the U.S. Food and Drug Administration (FDA) for providing a safer option for those with atrial fibrillation and atrial flutter. Dronedarone is the first new anti-arrhythmic drug approved in years for afib. There are now more options for fighting that afib beast. Read more:
As I’m sure you’re aware, both procedures have substantial risks - reason enough to postpone either. As this article illustrates, new medications that promise better results and fewer side effects are beginning to surface. From personal experience I can say waiting is often the best thing to do; the ONE anti-coagulant I could tolerate was stricken from the list just before my stent placement could be done! Still, if there is any financial aid for someone in your situation, your doctor or the American Heart Association should know how to apply for help. Best of luck to you!
- spam
- offensive
- disagree
- off topic
Like